万维提示：
1、投稿方式：在线投稿。
2、官网网址：http://biox.yiigle.com/
https://mednexus.org/journal/biox
https://journals.lww.com/jbioxresearch/pages/default.aspx
3、投稿网址：
https://www.editorialmanager.com/jbioxresearch/
自动跳转至：
https://www2.cloud.editorialmanager.com/jbioxresearch/default2.aspx
4、中华医学期刊全文数据库：
https://www.yiigle.com/Journal/Detail/179
5、出刊日期：季刊，逢季末月月末出版。
2024年2月23日星期五
《Journal of Bio-X Research》期刊简介
【中华医学期刊全文数据库官网信息】
《Journal of Bio-X Research》杂志是中国科协主管，中华医学会主办的英文学术期刊。本刊以广大基础和临床医学工作者为服务对象，重点报道国内外医学领域重大进展，关注生物学前沿技术在临床医学领域的推广和应用，专注于生物学与医学交叉领域的最新科研成果和诊断、治疗经验。
本刊专注于生物组学与医学交叉领域研究的国际学术论文发表，重点关注基因组学、转录组学、蛋白组学以及其它组学领域的前沿技术方法在临床领域的研究进展和应用。本刊涵盖生物学与医学多学科间的交叉研究成果，突出各组学研究平台的技术进步及其在复杂疾病的病因学，病理生理学，临床诊断和预防等诸多领域中的临床应用。本刊组建了国际化的编委会及编辑队伍，与国际出版平台开展合作，争取尽早被国际重要数据库收录并提高引证指标。
杂志将立足国内，面向国际，争取打造成为我国临床和基础医学研究领域的重要国际学术期刊，并为初步形成具有我国自主知识产权的国际一流科技期刊群，增强科技期刊服务创新能力，全面建成小康社会和创新型国家做出应有贡献。
主管： 中国科学技术协会
主办： 中华医学会
中文全称： 生物组学研究杂志（英文）
英文全称：Journal of Bio-X Research
英文简称：J Bio-X Res
刊期 ： 季刊
创刊时间 ：2018年
出版日期 ：3、6、9、12月末
刊物类型 ： 英文
总编 ： 贺林，David A. Weitz
负责人 ： 刘冰
电话 ：021-64173779
Email：bio-x@cmaph.org
地址 ： 上海市华山路1954号
邮编 ：200030
ISSN号 ：2096-5672
他引率 ：0.0
CN号 ：10-1558/R
定价 ：45元/期
《生物组学研究杂志（英文）》投稿须知
【官网信息】
Journal of Bio-X Research
Instructions for Authors
The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.
Email: qinwei@jbioxresearch.org
AIMS AND SCOPE
Journal of Bio-X Research is an international Open Access journal devoted to publishing peer-reviewed, high quality, original papers in a variety of fields at the cross boundaries between biology and medicine. The journal focuses on the development and application of cutting-edge methods in genomics, transcriptomics, proteomics and other “omics”. It provides the most comprehensive coverage in interdisciplinary research, spanning significant technical developments and applications of “omics” platforms in every area of etiology, pathophysiology, clinical treatment, and prevention of complex diseases. It publishes scientific investigation of the highest quality in the broad field of complex diseases, such as tumor, diabetes, hypertension, and soon.
ONLINE SUBMISSION
All manuscripts must be submitted online at: http://www.editorialmanager.com/jbioxresearch
First-time users
Please click the Register button at http://www.editorialmanager.com/jbioxresearch. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, you do not have to re-register.
Authors
Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the instructions for authors. You will be able to track the process of your manuscript through the system.
JOURNAL POLICIES
Duplicate Publication
Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to Journal of Bio-X Research and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team will subject all manuscripts submitted for consideration of publication in Journal of Bio-X Research to plagiarism-detection software.
This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.
Disclosure of Conflicts
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:" For example: “Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors, no relevant conflicts of interest were declared.”
Authorship
Journal of Bio-X Research expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.
Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall provide the data. Each author’s specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:
Participated in research design
Participated in the writing of the paper
Participated in the performance of the research
Contributed new reagents or analytic tools
Participated in data analysis
An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.
English Language Assistance
Appropriate use of the English language is a requirement for publication in Journal of Bio-X Research. Authors who have difficulty in writing in English who submit manuscripts to international journals often receive negative comments from referees or editors about the English-language usage in their manuscripts, and these challenges can contribute to a decision to reject a paper. To help reducing the possibility of such problems, we strongly encourage authors to consider using Wolters Kluwer Author Services**.
Wolters Kluwer, in partnership with Editage, offers a unique range of editorial services to help you prepare a submission-ready manuscript:
Premium Editing: Intensive language and structural editing of academic papers to increase changes of journal acceptance.
Advanced Editing: A complete language, grammar, and terminology check to give you a publication-ready manuscript.
Translation with Editing: Write your paper in your native language and Wolters Kluwer Author Services will translate it into English, as well as edit it to ensure that it meets international publication standards.
Plagiarism Check: Helps ensure that your manuscript contains no instances of unintentional plagiarism.
Artwork Preparation: Save precious time and effort by ensuring that your artwork is viewed favorably by the journal without you having to incur the additional cost of purchasing special graphics software.
For more information regarding Wolters Kluwer Author Services, please visit:
http://wkauthorservices.editage.com.
**Note that the use of such a service is at the author’s own expense and risk, and does not guarantee that the article will be accepted.
Reporting of Randomized Clinical Trials
Registration of Clinical Trials is an essential requirement for publication of clinical trials in Journal of Bio-X Research. On the title page of your manuscript, provide the name of the trial registry and the registration number/identifier of the trial.
……
更多详情：
https://edmgr.ovid.com/jbr/accounts/ifauth.htm
